{"data":[{"accessionNo":"0001493215-26-000100","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":"15673T100","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Roderick Wong","reportingCik":null,"personType":"HC,IN","sharesOwned":13043478,"percentOfClass":7.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001493215-26-000100","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":"15673T100","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"RTW Investments, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":13043478,"percentOfClass":7.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0000919574-26-003473","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":"15673T100","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5964678,"percentOfClass":3.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0000919574-26-003473","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":"15673T100","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":5964678,"percentOfClass":3.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0000919574-26-003473","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":"15673T100","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":5964678,"percentOfClass":3.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0000902664-26-001156","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-23","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":5961563,"percentOfClass":6.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0000902664-26-001156","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-23","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5961563,"percentOfClass":6.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0000902664-26-001156","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-23","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":5961563,"percentOfClass":6.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001346824-26-000006","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":17944649,"percentOfClass":9.9,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001346824-26-000006","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":17944649,"percentOfClass":9.9,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001346824-26-000006","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":17944649,"percentOfClass":9.9,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001346824-26-000006","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":17944649,"percentOfClass":9.9,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001738048-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"VHCP Management EG, LLC","reportingCik":null,"personType":"OO","sharesOwned":13043478,"percentOfClass":7.1,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001738048-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"Venrock Healthcare Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":13043478,"percentOfClass":7.1,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001738048-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"VHCP Co-Investment Holdings III, LLC","reportingCik":null,"personType":"OO","sharesOwned":13043478,"percentOfClass":7.1,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001738048-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"Venrock Healthcare Capital Partners EG, L.P.","reportingCik":null,"personType":"PN","sharesOwned":13043478,"percentOfClass":7.1,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001738048-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"VHCP Management III, LLC","reportingCik":null,"personType":"OO","sharesOwned":13043478,"percentOfClass":7.1,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001738048-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"Nimish Shah","reportingCik":null,"personType":"IN","sharesOwned":13043478,"percentOfClass":7.1,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001738048-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"Bong Y. Koh","reportingCik":null,"personType":"IN","sharesOwned":13043478,"percentOfClass":7.1,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001831942-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"Commodore Capital LP","reportingCik":null,"personType":"PN,IA","sharesOwned":13043478,"percentOfClass":7.1,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001831942-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"Commodore Capital Master LP","reportingCik":null,"personType":"PN","sharesOwned":13043478,"percentOfClass":7.1,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001831942-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"Robert Egen Atkinson","reportingCik":null,"personType":"HC,IN","sharesOwned":13043478,"percentOfClass":7.1,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001831942-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"Michael Kramarz","reportingCik":null,"personType":"IN,HC","sharesOwned":13043478,"percentOfClass":7.1,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001193125-26-014129","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"Chen Yu","reportingCik":null,"personType":"IN","sharesOwned":17754430,"percentOfClass":9.9,"filedAt":"2026-01-15","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001172661-26-000198","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-08","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":13486400,"percentOfClass":7.34,"filedAt":"2026-01-15","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001172661-26-000198","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-08","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":13486400,"percentOfClass":7.34,"filedAt":"2026-01-15","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001172661-26-000198","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-08","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":10609008,"percentOfClass":5.78,"filedAt":"2026-01-15","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001193125-26-014129","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"TCG Crossover GP II, LLC","reportingCik":null,"personType":"OO","sharesOwned":8877215,"percentOfClass":4.9,"filedAt":"2026-01-15","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001193125-26-014129","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"TCG Crossover Fund II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":8877215,"percentOfClass":4.9,"filedAt":"2026-01-15","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001193125-26-014129","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"TCG Crossover GP III, LLC","reportingCik":null,"personType":"OO","sharesOwned":8877215,"percentOfClass":4.9,"filedAt":"2026-01-15","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001193125-26-014129","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-09","reportingPerson":"TCG Crossover Fund III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":8877215,"percentOfClass":4.9,"filedAt":"2026-01-15","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001172661-26-000198","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-08","reportingPerson":"Deep Track Special Opportunities Fund, LP.","reportingCik":null,"personType":"PN","sharesOwned":2877392,"percentOfClass":1.57,"filedAt":"2026-01-15","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0000902664-26-000035","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-23","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4725639,"percentOfClass":5.4,"filedAt":"2026-01-05","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0000902664-26-000035","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-23","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":4725639,"percentOfClass":5.4,"filedAt":"2026-01-05","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0000902664-26-000035","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001850119","issuerName":"Century Therapeutics, Inc.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-23","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":4725639,"percentOfClass":5.4,"filedAt":"2026-01-05","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"},{"accessionNo":"0001193125-25-283095","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001850119","issuerName":"CENTURY THERAPEUTICS, INC.","ticker":"IPSC","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Bain Capital Life Sciences Opportunities III, LP","reportingCik":null,"personType":"PN","sharesOwned":3538609,"percentOfClass":4.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc"}],"updatedAt":"2026-11-03T17:39:11.233Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ipsc","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}